# A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster

> **NCT05492591** · PHASE2 · COMPLETED · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 50 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **DRUG:** Peginterferon α1b
- **DRUG:** Peginterferon α1b with valacyclovir
- **DRUG:** Valacyclovir

## Key facts

- **NCT ID:** NCT05492591
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-11
- **Primary completion:** 2023-07-22
- **Final completion:** 2023-07-22
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05492591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05492591, "A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05492591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*